793: Baseline analysis of Q-ABC- prospective study comparing radiotherapy and surgery for bladder cancer

A. Nikapota, Sally Appleyard, Isobelle Coombes, Ruth Habibi, Angus Robinson(Royal Sussex County Hospital), Y. Rimmer, Peter Hoskin(University of Manchester), Stephen Bremner(Brighton and Sussex Medical School), Gaurav Kapur(Children's Hospital of Michigan), Ananya Choudhury(University of Manchester), Chris I. Jones(University of Leicester), Jo Cresswell, Morro Touray, Duncan C. Gilbert(Royal Sussex County Hospital), Isabel Syndikus(San Antonio College), Sue Catt, Heather Gage, Mohini Varughese(Musgrove Park Hospital), Shirley May
Radiotherapy and Oncology
May 1, 2024
10.1016/s0167-8140(24)01327-6
Cited by 0

Related Papers

Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
|New England Journal of Medicine|2013|3.3k
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
|The Lancet|2015|2k
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
|New England Journal of Medicine|2017|1.8k
The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies
|Clinical and Translational Radiation Oncology|2018|932
Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study
|Radiotherapy and Oncology|2016|695